ConcePTION
Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed workflows for fast, optimised evidence generation
Site Search
Site Search
Displaying results 351 - 360 of 893
MELLODDY
Machine learning ledger orchestration for drug discovery
TransBioLine
Translational Safety Biomarker Pipeline (TransBioLine): Enabling development and implementation of novel safety biomarkers in clinical trials and diagnosis of disease
91st Edition – June 2019
Table of contents:
- Advanced therapies feature in new IMI Call for proposals
- IMI launches new Call for proposals to help existing projects build on achievements
- Interested in IMI2 – Call 18 or 19? Check IMI’s tips for applicants
- Calling all patients – apply to be part of IMI’s pool of patient experts
- Catch up on the IMI Stakeholder Forum 2019
- IMI at BIO 2019
- Sign up for the European Research and Innovation Days
- News from the projects
Advanced therapies feature in new IMI Call for proposals
Brussels, Belgium, 26 June 2019 – Advanced therapies are a major part of new Innovative Medicines Initiative (IMI) Calls for proposals launched today. The two advanced therapies topics aim to accelerate research into advanced therapies for rare diseases, and support the ...
IMI2 - Call 19
IMI 2 - Call 19 was launched on 26 June 2019 with the following topic: Restricted Call to maximise impact of IMI2 JU objectives and scientific priorities More information on the topic can be found in IMI's press release and in the Call text. Other relevant documents can be found ...
IMI2 - Call 18
IMI2 – Call 18 was launched on 26 June 2019 with the following topics: Central repository of digital pathology slides to support the development of artificial intelligence tools Health Outcomes Observatories – empower patients with tools to measure their outcomes in a ...
IMI to boost patient involvement in its activities
Brussels, Belgium, 28 May 2019 – The Innovative Medicines Initiative (IMI) is creating a ‘pool’ of patient experts to strengthen the role and voice of patients in IMI activities at both strategic and operational levels. IMI has always involved patients in its work; now the plan ...